Cilengitide: A Potent Integrin Inhibitor for Advanced Cancer Therapy
Explore the groundbreaking potential of Cilengitide in targeting critical pathways for cancer treatment.
Get a Quote & SampleProduct Core Value

Cilengitide
Cilengitide is a potent and selective inhibitor of integrins αvβ3 and αvβ5, crucial targets in angiogenesis and tumor progression. This synthetic cyclic peptide represents a significant advancement in targeted cancer therapies.
- Leveraging selective integrin antagonism for cancer treatment, Cilengitide offers a novel approach to combatting tumor growth.
- As an angiogenesis inhibitor, it disrupts the formation of new blood vessels essential for tumor survival and expansion.
- Its investigation for glioblastoma treatment highlights its potential in addressing aggressive and challenging cancers.
- The RGD sequence in its structure allows for potent inhibition of integrin-ligand binding, a key mechanism in its anti-tumor activity.
Key Advantages of Cilengitide
Targeted Action
Cilengitide precisely targets αvβ3 and αvβ5 integrins, minimizing off-target effects and enhancing therapeutic efficacy in cancer by blocking key cellular processes.
Inhibits Tumor Growth
By disrupting angiogenesis and influencing tumor invasion, Cilengitide acts as a powerful tool against tumor progression, offering new hope in oncology.
Synergistic Potential
Studies suggest Cilengitide can augment the effects of other cancer treatments, like radiation therapy, potentially leading to better patient outcomes.
Key Applications
Oncology Research
Essential for studying the role of integrins in cancer development and progression, aiding in the discovery of new treatment strategies.
Angiogenesis Inhibition Studies
A critical tool for researchers investigating anti-angiogenic therapies and their impact on tumor vascularization and growth.
Glioblastoma Treatment Development
Key in the research and development of novel treatments for glioblastoma, a highly aggressive brain tumor.
Integrin Signaling Pathways
Used to dissect the complex roles of integrin signaling in various cellular processes relevant to disease and therapeutic intervention.